IBDEI10L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16878,0)
 ;;=M53.9^^88^856^29
 ;;^UTILITY(U,$J,358.3,16878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16878,1,3,0)
 ;;=3^Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16878,1,4,0)
 ;;=4^M53.9
 ;;^UTILITY(U,$J,358.3,16878,2)
 ;;=^5012284
 ;;^UTILITY(U,$J,358.3,16879,0)
 ;;=M43.9^^88^856^25
 ;;^UTILITY(U,$J,358.3,16879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16879,1,3,0)
 ;;=3^Deforming Dorsopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16879,1,4,0)
 ;;=4^M43.9
 ;;^UTILITY(U,$J,358.3,16879,2)
 ;;=^5011959
 ;;^UTILITY(U,$J,358.3,16880,0)
 ;;=R60.1^^88^856^30
 ;;^UTILITY(U,$J,358.3,16880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16880,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,16880,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,16880,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,16881,0)
 ;;=R60.0^^88^856^31
 ;;^UTILITY(U,$J,358.3,16881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16881,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,16881,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,16881,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,16882,0)
 ;;=R60.9^^88^856^32
 ;;^UTILITY(U,$J,358.3,16882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16882,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,16882,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,16882,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,16883,0)
 ;;=M72.9^^88^856^33
 ;;^UTILITY(U,$J,358.3,16883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16883,1,3,0)
 ;;=3^Fibroblastic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16883,1,4,0)
 ;;=4^M72.9
 ;;^UTILITY(U,$J,358.3,16883,2)
 ;;=^5013237
 ;;^UTILITY(U,$J,358.3,16884,0)
 ;;=M79.7^^88^856^34
 ;;^UTILITY(U,$J,358.3,16884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16884,1,3,0)
 ;;=3^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,16884,1,4,0)
 ;;=4^M79.7
 ;;^UTILITY(U,$J,358.3,16884,2)
 ;;=^46261
 ;;^UTILITY(U,$J,358.3,16885,0)
 ;;=M84.50XA^^88^856^36
 ;;^UTILITY(U,$J,358.3,16885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16885,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,16885,1,4,0)
 ;;=4^M84.50XA
 ;;^UTILITY(U,$J,358.3,16885,2)
 ;;=^5014022
 ;;^UTILITY(U,$J,358.3,16886,0)
 ;;=M84.50XD^^88^856^39
 ;;^UTILITY(U,$J,358.3,16886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16886,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Routine Healing
 ;;^UTILITY(U,$J,358.3,16886,1,4,0)
 ;;=4^M84.50XD
 ;;^UTILITY(U,$J,358.3,16886,2)
 ;;=^5014023
 ;;^UTILITY(U,$J,358.3,16887,0)
 ;;=M84.50XS^^88^856^40
 ;;^UTILITY(U,$J,358.3,16887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16887,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Sequela
 ;;^UTILITY(U,$J,358.3,16887,1,4,0)
 ;;=4^M84.50XS
 ;;^UTILITY(U,$J,358.3,16887,2)
 ;;=^5014027
 ;;^UTILITY(U,$J,358.3,16888,0)
 ;;=M84.50XG^^88^856^35
 ;;^UTILITY(U,$J,358.3,16888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16888,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Delayed Healing
 ;;^UTILITY(U,$J,358.3,16888,1,4,0)
 ;;=4^M84.50XG
 ;;^UTILITY(U,$J,358.3,16888,2)
 ;;=^5014024
 ;;^UTILITY(U,$J,358.3,16889,0)
 ;;=M84.50XK^^88^856^38
 ;;^UTILITY(U,$J,358.3,16889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16889,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Nonunion
 ;;^UTILITY(U,$J,358.3,16889,1,4,0)
 ;;=4^M84.50XK
 ;;^UTILITY(U,$J,358.3,16889,2)
 ;;=^5014025
 ;;^UTILITY(U,$J,358.3,16890,0)
 ;;=M84.50XP^^88^856^37
 ;;^UTILITY(U,$J,358.3,16890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16890,1,3,0)
 ;;=3^Fx in Neoplastic Disease,Unspec Site,Malunion
 ;;^UTILITY(U,$J,358.3,16890,1,4,0)
 ;;=4^M84.50XP
 ;;^UTILITY(U,$J,358.3,16890,2)
 ;;=^5014026
